| Lung Cancer |
1 |
1 |
| Non-Small Cell Lung Cancer |
0 |
0.99 |
| Breast Cancer |
0 |
0.85 |
| Advanced and Metastatic Breast Cancer |
0 |
0.69 |
| Cancer |
0 |
0.65 |
| Small Cell Lung Cancer |
0 |
0.63 |
| Biologic Therapy |
0 |
0.6 |
| Toxicology |
0 |
0.51 |
| Targeted Cancer Therapy |
0 |
0.5 |
| Metastasis |
0 |
0.49 |
| Breast |
0 |
0.48 |
| Lung |
0 |
0.3 |
| Radiation Therapy |
0 |
0.98 |
| Arrhythmia |
0 |
0.12 |
| Clinical Research |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.08 |
| Medical Life |
0 |
0.05 |
| Ablation |
0 |
0.04 |
| Chemotherapy |
0 |
0.04 |
| Clinician Health and Well-Being |
0 |
0.04 |
| Estrogen |
0 |
0.04 |
| Health Care Facilities, Manpower, and Services |
0 |
0.04 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Immunotherapy |
0 |
0.04 |
| New York |
0 |
0.04 |
| Positron Emission Tomography |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Washington |
0 |
0.04 |